TrialThe Lancet. Infectious diseases2018

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial.

David Goldblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.